Table 2. Characteristics of patients’ XBJ medication use.
| Variables | Number (%) |
|---|---|
| Use for the first time | |
| Yes | 28,627 (89.70) |
| No | 914 (2.86) |
| Unclear | 2372 (7.43) |
| Dosage (one time) | |
| <50 mL | 5,603 (17.56) |
| 50–100 mL | 26,219 (82.16) |
| >100 mL | 91 (0.29) |
| Medication time (days) | |
| Mean ± SD | 6.5±4.55 |
| Median | 5.0 |
| Range | 1.0–40.0 |
| Frequency | |
| 1 time/day | 20,947 (65.64) |
| 2–3 times/day | 10,948 (34.31) |
| 4 times/day | 18 (0.06) |
| Solvent | |
| 0.9% normal saline | 30,187 (94.59) |
| Others | 1,726 (5.41) |
| Amount of solvents | |
| NA | 485 (1.52) |
| <100 mL | 387 (1.21) |
| 100 mL | 24,835 (77.82) |
| >100 mL | 5,787 (18.13) |
| Administration | |
| Intravenous dripping | 31,494 (98.69) |
| Others | 419 (1.31) |
| Dripping speed | |
| <30 drops/min | 1,724 (5.40) |
| 30–60 drops/min | 21,856 (68.49) |
| 60–80 drops/min | 7,604 (23.83) |
| 80–100 drops/min | 455 (1.43) |
| >100 drops/min | 87 (0.27) |
| Unclear | 187 (0.59) |